MAPK8IP1P2 and thyroid cancer: Gain and loss of function assays demonstrated that upregulating MAPK8IP1P2 inhibited, while silencing MAPK8IP1P2 promoted anoikis resistance in vitro and lymphatic metastasis of thyroid cancer cells in vivo.